Mitochondrial antiviral signaling protein: a potential therapeutic target in renal disease
- PMID: 37901251
- PMCID: PMC10602740
- DOI: 10.3389/fimmu.2023.1266461
Mitochondrial antiviral signaling protein: a potential therapeutic target in renal disease
Abstract
Mitochondrial antiviral signaling protein (MAVS) is a key innate immune adaptor on the outer mitochondrial membrane that acts as a switch in the immune signal transduction response to viral infections. Some studies have reported that MAVS mediates NF-κB and type I interferon signaling during viral infection and is also required for optimal NLRP3 inflammasome activity. Recent studies have reported that MAVS is involved in various cancers, systemic lupus erythematosus, kidney diseases, and cardiovascular diseases. Herein, we summarize the structure, activation, pathophysiological roles, and MAVS-based therapies for renal diseases. This review provides novel insights into MAVS's role and therapeutic potential in the pathogenesis of renal diseases.
Keywords: MAVS; NLRP3; inflammation; innate immune; renal disease.
Copyright © 2023 Wu, Pei, Long, Chen, Jia and Xia.
Conflict of interest statement
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest. The author(s) declared that they were an editorial board member of Frontiers, at the time of submission. This had no impact on the peer review process and the final decision.
Figures
Similar articles
-
Identification and characterization of MAVS, a mitochondrial antiviral signaling protein that activates NF-kappaB and IRF 3.Cell. 2005 Sep 9;122(5):669-82. doi: 10.1016/j.cell.2005.08.012. Cell. 2005. PMID: 16125763
-
TRAF5 is a downstream target of MAVS in antiviral innate immune signaling.PLoS One. 2010 Feb 11;5(2):e9172. doi: 10.1371/journal.pone.0009172. PLoS One. 2010. PMID: 20161788 Free PMC article.
-
DDIT3 Targets Innate Immunity via the DDIT3-OTUD1-MAVS Pathway To Promote Bovine Viral Diarrhea Virus Replication.J Virol. 2021 Feb 24;95(6):e02351-20. doi: 10.1128/JVI.02351-20. Print 2021 Feb 24. J Virol. 2021. PMID: 33361422 Free PMC article.
-
Orchestrating the interferon antiviral response through the mitochondrial antiviral signaling (MAVS) adapter.Curr Opin Immunol. 2011 Oct;23(5):564-72. doi: 10.1016/j.coi.2011.08.001. Epub 2011 Aug 22. Curr Opin Immunol. 2011. PMID: 21865020 Review.
-
Regulation of MAVS Expression and Signaling Function in the Antiviral Innate Immune Response.Front Immunol. 2020 May 27;11:1030. doi: 10.3389/fimmu.2020.01030. eCollection 2020. Front Immunol. 2020. PMID: 32536927 Free PMC article. Review.
Cited by
-
Attenuating mitochondrial dysfunction-derived reactive oxygen species and reducing inflammation: the potential of Daphnetin in the viral pneumonia crisis.Front Pharmacol. 2024 Oct 18;15:1477680. doi: 10.3389/fphar.2024.1477680. eCollection 2024. Front Pharmacol. 2024. PMID: 39494349 Free PMC article. Review.
-
Understanding the impact of in vitro transcription byproducts and contaminants.Front Mol Biosci. 2024 Jul 10;11:1426129. doi: 10.3389/fmolb.2024.1426129. eCollection 2024. Front Mol Biosci. 2024. PMID: 39050733 Free PMC article. Review.
-
Mitochondrial oxidative stress, mitochondrial ROS storms in long COVID pathogenesis.Front Immunol. 2023 Dec 22;14:1275001. doi: 10.3389/fimmu.2023.1275001. eCollection 2023. Front Immunol. 2023. PMID: 38187378 Free PMC article. Review.
References
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous